C Y Firestone
Overview
Explore the profile of C Y Firestone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crowe Jr J, Firestone C, Murphy B
J Immunol
. 2001 Sep;
167(7):3910-8.
PMID: 11564809
A respiratory syncytial virus (RSV) vaccine will need to be administered by 1 mo of age to protect young infants; therefore, it will need to be effective in the presence...
2.
Blaney Jr J, Johnson D, Firestone C, Hanson C, Murphy B, Whitehead S
J Virol
. 2001 Sep;
75(20):9731-40.
PMID: 11559806
A recombinant live attenuated dengue virus type 4 (DEN4) vaccine candidate, 2ADelta30, was found previously to be generally well tolerated in humans, but a rash and an elevation of liver...
3.
Whitehead S, Hill M, Firestone C, St Claire M, Elkins W, Murphy B, et al.
J Virol
. 1999 Nov;
73(12):9773-80.
PMID: 10559287
Human respiratory syncytial virus (RSV) exists as two antigenic subgroups, A and B, both of which should be represented in a vaccine. The F and G glycoproteins are the major...
4.
Juhasz K, Whitehead S, Boulanger C, Firestone C, Collins P, Murphy B
Vaccine
. 1999 Apr;
17(11-12):1416-24.
PMID: 10195777
cpts530/1009 is a live-attenuated, temperature-sensitive (ts) RSV vaccine candidate that was shown previously to be attenuated for seronegative humans. It was generated by two rounds of chemical mutagenesis: first, a...
5.
Whitehead S, Bukreyev A, Teng M, Firestone C, St Claire M, Elkins W, et al.
J Virol
. 1999 Mar;
73(4):3438-42.
PMID: 10074199
The NS2 and SH genes of respiratory syncytial virus (RSV) have been separately deleted from a recombinant wild-type RSV strain, A2 (M. N. Teng and P. L. Collins, J. Virol....
6.
Whitehead S, Firestone C, Karron R, Crowe Jr J, Elkins W, Collins P, et al.
J Virol
. 1999 Jan;
73(2):871-7.
PMID: 9882287
Respiratory syncytial virus (RSV) cpts530/1030 is an attenuated, temperature-sensitive subgroup A vaccine candidate derived previously from cold-passaged RSV (cpRSV) by two sequential rounds of chemical mutagenesis and biological selection. Here,...
7.
Crowe J, Firestone C, Crim R, Beeler J, Coelingh K, Barbas C, et al.
Virology
. 1999 Jan;
252(2):373-5.
PMID: 9878616
A recombinant human antibody fragment, designated RSV Fab 19, efficiently neutralizes respiratory syncytial virus (RSV). Here we report the results of our sequence analysis of antibody escape mutants that identified...
8.
Whitehead S, Firestone C, Collins P, Murphy B
Virology
. 1998 Aug;
247(2):232-9.
PMID: 9705916
Respiratory syncytial virus (RSV) cpts248/404 is a live-attenuated, temperature-sensitive (ts) vaccine candidate derived from cole-passaged cpRSV by two rounds of chemical mutagenesis and biological selection. Previous sequence analysis showed that...
9.
Whitehead S, Juhasz K, Firestone C, Collins P, Murphy B
J Virol
. 1998 Apr;
72(5):4467-71.
PMID: 9557743
A set of five missense mutations previously identified by nucleotide sequence analysis of subgroup A cold-passaged (cp) respiratory syncytial virus (RSV) has been introduced into a recombinant wild-type strain of...
10.
Firestone C, Whitehead S, Collins P, Murphy B, Crowe Jr J
Virology
. 1996 Nov;
225(2):419-22.
PMID: 8918930
The complete nucleotide sequence of the RSV cpts-248/404 live attenuated vaccine candidate was determined from cloned cDNA and was compared to that of the RSV A2/HEK7 wild-type, cold-passaged cp-RSV, and...